Liquichek™ Maternal Serum II Control

Date: 
2016-06-06
 

Product Press Release

Bio-Rad Announces the Release of Liquichek™ Maternal Serum II Control

The Multi-Constituent Control Offers Increased Efficiency and Confidence in Test Results

HERCULES, CA – June 6, 2016 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announces the release of Liquichek Maternal Serum II Control, a frozen liquid human serum-based material designed to monitor the precision of laboratory test procedures used during maternal serum second trimester screening.

Liquichek Maternal Serum II Control includes AFP, Free Estriol, hCG and Inhibin A, making it ideal for laboratories performing triple or quadruple marker screening. The liquid form eliminates the need for reconstitution, increasing efficiency and allowing samples to be treated the same way as patient specimens. As an independent quality control, Liquichek Maternal Serum II Control is not optimized for a specific test system and provides laboratories greater confidence in patient results.

Key Benefits
Liquichek Maternal Serum II Control is a multi-constituent control:

  • Designed for use on various instruments and reagent systems
  • Offer three-year shelf life when stored at -20 to -70°C and open-vial stability of 30 days when stored between 2°C to 8°C
  • Available in three individual levels

When used with Bio-Rad’s Unity™ Interlaboratory Program, the world’s largest comparison peer group and Unity Real Time®, an expert data management software solution designed to improve the effectiveness of quality control processes, maternal serum testing laboratories are provided with the industry’s most complete solution for daily, optimized quality controls. In addition, Unity Interlaboratory Program participants are able to access their reports online at QCNet™.

For over 25 years Bio-Rad has been a leader in providing quality control products, technical support, as well as data management software solutions that improve the effectiveness of quality control processes. For more information, please call 1-800-2-BIORAD (1-800-224-6723) or visit www.bio-rad.com


About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,800 people worldwide and had revenues exceeding $2 billion in 2015. For more information, please visit www.bio rad.com.

Press contact:
Angela Suh, Product Manager
Bio-Rad Laboratories, Inc.
949-598-1200
angela_suh@bio-rad.com